Ireland· IE-PA-EU/1/99/097/001
Beromun 1 mg powder for solution for infusion
A tasonermin product containing tumour necrosis factor alfa 1a, registered in Ireland by Belpharma S.A.. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tasonermin is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AX11 (tasonermin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Tasonermin · ATC L03AX11
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Tumour necrosis factor alfa 1a
- Manufacturer
- Belpharma S.A.
- Country
- Ireland (IE)
- ATC code
- L03AX11
- ATC class
- Tasonermin
- Defined daily dose
- 3.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/99/097/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L03AX11
Tasonermin, as other registers publish it.
- PolandBeromunBELPHARMA s.a.
- FinlandBeromunBELPHARMA s.a.
- DenmarkBeromunBELPHARMA s.a.
- CzechiaBEROMUNBELPHARMA s.a., Luxembourg
- BelgiumBeromun 1 mgBelpharma
- NetherlandsBeromun 1 mg poeder voor oplossing voor infusieBelpharma s.a.
- FranceBEROMUN 1 mg, poudre pour solution pour perfusionBELPHARMA (LUXEMBOURG)
- United KingdomBeromun 1mg powder and solvent for solution for infusion vialsBoehringer Ingelheim Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/41584dbc-047a-4dea-82bd-27f4f4b565b8 GET /v1/drugs/41584dbc-047a-4dea-82bd-27f4f4b565b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"routes": [
"Unknown"
],
"source": "hpra",
"atc_all": [
"L03AX",
"L03AX11"
],
"strength": null,
"pa_number": "EU/1/99/097/001",
"substances": [
"Tumour necrosis factor alfa 1a"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "13/04/1999",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tasonermin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.